Phase 1 study of pandemic H1 DNA vaccine in healthy adults - Test2 - elhamkhani - TriplyDB

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

http://www.wikidata.org/entity/Q30373824

about

Refining the approach to vaccines against influenza A viruses with pandemic potential.Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.New Vaccine Technologies to Combat Outbreak Situations A Review of DNA Vaccines Against Influenza

P2860

Q30381595-E1299F43-FD49-43BB-8895-A42CA7E8E07B Q30399700-2CF195B3-EAB3-41B1-B82C-E78DCF535587 Q36573064-1E744F05-FC2D-42C4-9787-9DCC7859058B Q47105782-0524FB12-4D2F-465C-ABFA-5337A899A45D Q50308620-2CC661AC-5D54-4896-8DDA-A16FF813CB36 Q57072744-FEB83406-BBF9-4DFF-9AE0-C1CB90F6AD8A Q57094261-A40F9CF5-3C33-4B6F-B0E6-D57BB1C4939D

P2860

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

http://www.wikidata.org/entity/Q30373824

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

@ast

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

@en

type

label

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

@ast

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

@en

prefLabel

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

@ast

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

@en

P1433

Q30373824-EB6C97EC-54B8-4B80-AAE7-FBC719E94E46

P1476

Q30373824-C5E1E815-6E22-401C-B297-ED9DB276928F

P2093

Q30373824-16C4AD1F-0BC3-42CC-8AB2-07DA3A381BA1

Q30373824-25DCD570-1E89-4061-A4FB-34B0F0D07A76

Q30373824-5569EEE3-5D0F-4CBC-A6BA-26D63EA0D17C

Q30373824-5679967E-D8E0-4D0D-B260-E7E4221489A8

Q30373824-61BE83F1-4415-4652-93D4-14999BED0F46

Q30373824-7698FDE8-A3C3-4CE6-AD4C-C5F14688B362

Q30373824-7F71833D-7926-4A45-BFD5-4EF61F6C3242

Q30373824-81D27098-F4B1-4BC2-9130-585FAF6E161A

Q30373824-974FDFC4-36EF-4E3B-B972-0ED3651E339B

Q30373824-9DD64173-E1BC-4804-8BFC-F9FFCB744FD4

P2860

Q30373824-02578B86-826D-4B13-94F2-9A86F07D7330

Q30373824-0A4D3801-935A-495C-A46B-E406F87ABDF4

Q30373824-11E06082-E6BB-4889-9EEE-2E770AFF8139

Q30373824-15808D85-A08E-48A4-AF86-6F519088C41D

Q30373824-21A0760D-7B5D-4B9B-8D94-F4EE62E2C2AB

Q30373824-2864E6BF-7657-4064-9F98-E7D5B8D15BC5

Q30373824-2E79AD1A-CF73-4F41-853B-50ABC17E8BA7

Q30373824-3646F788-766E-4DBE-9DCE-1169DAD19D7E

Q30373824-3B36D955-D07D-4949-9527-F8FBABC14427

Q30373824-501C7F54-3BA6-439D-AE11-5599853FD3CF

P304

Q30373824-CE97FDD1-25D0-49D3-87CB-96EA24A27764

P31

Q30373824-651756B6-9D4D-44F3-9B6A-EFEA201CE86C

P356

Q30373824-291B0BAA-B57B-4D12-97A8-54A19F361452

P407

Q30373824-B62A1465-3474-45AB-95A2-95EF181F3CEE

P433

Q30373824-7C9C9E41-733D-4365-8FF2-2548AB2F39F9

P478

Q30373824-BB5A02EE-024B-48CC-80F8-3966F88B6635

P50

Q30373824-0CD7CEF2-98E2-4E2B-BF36-86815AC49DF7

Q30373824-36358EB4-7720-4F65-A3DF-619859256E15

Q30373824-B2E1459F-DB15-49AD-9DBF-5F7F02D7CD39

Q30373824-DB3A2D1F-1C56-41AC-B7C3-AC3E2AF81E41

Q30373824-DDD66525-6998-4403-B245-E21C3984F7CE

Q30373824-F8B5F8AE-8A42-43E6-B3CB-30BCF062055E

P577

Q30373824-6FD6854D-A12D-4EE9-8986-DDC9354029CF

P5875

Q30373824-93D391A7-D919-44C5-B16D-06658A61C80F

P698

Q30373824-D4BE9CCC-18F1-4CBE-A2CE-E2949400BC5E

P921

Q30373824-5CE81F24-A35F-42A6-9367-85DE60BFA55F

P932

Q30373824-2A42059E-6905-40B8-842E-716260809591

P356

JOURNAL.PONE.0123969

P1433

P1476

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

@en

P2093

Galina V Yamshchikov

http://www.w3.org/2001/XMLSchema#string

Ingelise J Gordon

http://www.w3.org/2001/XMLSchema#string

LaSonji A Holman

http://www.w3.org/2001/XMLSchema#string

Mary E Enama

http://www.w3.org/2001/XMLSchema#string

Michelle C Crank

http://www.w3.org/2001/XMLSchema#string

Richard A Koup

http://www.w3.org/2001/XMLSchema#string

Richard M Schwartz

http://www.w3.org/2001/XMLSchema#string

Robert T Bailer

http://www.w3.org/2001/XMLSchema#string

Sandra Sitar

http://www.w3.org/2001/XMLSchema#string

VRC 308 Study Team

http://www.w3.org/2001/XMLSchema#string

P2860

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

Response to a monovalent 2009 influenza A (H1N1) vaccine.

A novel influenza A (H1N1) vaccine in various age groups.

P304

e0123969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0123969

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Julie Ledgerwood

Terrence M Tumpey

Melissa B Pearce

Barney S. Graham

P577

2015-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276100880

http://www.w3.org/2001/XMLSchema#string

P698

25884189

http://www.w3.org/2001/XMLSchema#string

P921

P932

4401709

http://www.w3.org/2001/XMLSchema#string